Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COVID-19 research v0.36 | TAP2 |
Ellen McDonagh gene: TAP2 was added gene: TAP2 was added to Viral susceptibility. Sources: Expert Review Green,ESID Registry 20171117,North West GLH,Victorian Clinical Genetics Services,GRID V2.0,NHS GMS,GOSH PID v.8.0,London North GLH,IUIS Classification February 2018 Mode of inheritance for gene: TAP2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TAP2 were set to 10560675; 11529920; 20083708; 7517574 Phenotypes for gene: TAP2 were set to Vasculitis, pyoderma gangrenosum; Bare lymphocyte syndrome, type I, due to TAP2 deficiency 604571; HLA class I deficiency; Immunodeficiencies affecting cellular and humoral immunity; Wegener-like granulomatosis |